← Open Payments lookup

ERIN WALLER: Open Payments

NPI 1578036349 · RUSTON, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$147 in 8 payments from 8 companies in 2025. Trend: 2023 $341 · 2024 $122 · 2025 $147

Food & beverage: $147
CompanyPaymentsAmount
Sumitomo Pharma America, Inc.1$32
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$19
Insulet Corporation1$18
Astellas Pharma US Inc1$16
Exeltis, USA Inc.1$16
Novo Nordisk Inc1$15
Takeda Pharmaceuticals U.S.A., Inc.1$15
Exact Sciences Corporation1$15

Products named: MYFEMBREE, CAPLYTA, Omnipod, Veozah, SLYND, Wegovy, TRINTELLIX, Cologuard Collection Kit.

Industry payments across LA — which companies pay providers there.